4.7 Article

First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 7, Pages 4331-4335

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00127-15

Keywords

-

Funding

  1. Astellas
  2. Pfizer
  3. Merck
  4. Gilead
  5. MSD
  6. Basilea

Ask authors/readers for more resources

Azole resistance in Aspergillus fumigatus is an emerging public health concern. Recently, a novel fungicide-driven mutation in the cyp51A gene and its promoter, TR46/Y121F/T289A, leading to high-level resistance to voriconazole has been identified in The Netherlands, Belgium, Germany, Denmark, Tanzania, and India in both clinical and environmental samples. Here we report the first description of A. fumigatus carrying this mutation in France, in a cystic fibrosis patient, underlining the need for extensive monitoring of Aspergillus resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available